Financial Reports Latest Updates Industry Maps Economic Calendar

DocGo Inc. (DCGO) Annual Reports

Q: Where can I read DocGo Inc. (DCGO) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

DocGo Inc. is listed on Nasdaq, classified by the SEC under Services-Health Services (SIC 8000). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1822359 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$73.4M	$80.4M	-8.7%
Operating income	$-17.9M	$-17.5M	-2.5%
Net income	$-15.8M	$-11.2M	-41.8%
EPS (diluted)	$-0.16	$-0.11	-45.5%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 73.4 mn Net income -15.8 mn

Show table：Income statement

Item	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	—	94.1	49.7	62.2	85.8	121	118	110	104	109	113	125	187	199	192	165	139	121	96.0	80.4	70.8	74.9	75.5	73.4
Operating income	0	-0.17	-0.38	-0.25	-0.35	16.3	10.1	7.46	4.20	0.08	-6.90	1.58	8.71	11.7	15.9	10.2	10.1	-7.47	-14.0	-17.5	-42.0	-105	-18.7	-17.9
Net income	0	-0.15	1.99	-3.04	0.54	19.7	9.37	11.8	2.47	11.0	-3.47	1.34	4.63	4.80	11.2	6.53	5.50	-3.26	-9.41	-11.2	-27.8	-134	-14.8	-15.8

Balance sheet

Quarterly · In mn (USD)

Total assets 187 mn Total liabilities 91.0 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	0	1.05	0.72	0.46	0.29	256	268	276	252	271	258	234	267	339	335	329	328	304	263	237	190	152	138	120
Total assets	0.11	116	116	115	115	310	325	332	356	393	408	390	420	490	491	488	494	456	431	408	354	217	209	187
Current liabilities	0.09	0.16	0.18	0.16	0.33	57.9	61.0	57.9	71.1	100	109	91.8	113	170	160	154	150	122	108	100	73.6	67.5	77.2	72.3
Total liabilities	—	4.18	10.9	13.7	12.9	82.5	84.9	77.5	85.1	114	124	106	128	185	176	170	169	140	129	121	93.1	91.2	98.0	91.0
Equity	0.02	5.00	5.00	5.00	-12.7	220	232	247	264	273	279	280	288	301	311	315	325	321	309	297	271	144	132	119

Cash flow

Quarterly · In mn (USD)

Operating -9.24 mn Investing -3.88 mn Financing -1.66 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	0	-0.25	-0.41	-0.26	-0.18	-1.09	18.3	11.9	7.42	-8.74	-23.1	10.7	-45.9	-5.92	-10.6	37.1	31.0	12.9	9.66	33.6	1.66	-10.5	-4.66	-9.24
Investing	—	-115	0.03	0	0.01	-8.63	-1.14	-0.82	-35.8	-0.65	-1.69	-23.7	-1.50	-2.96	-1.70	-2.09	-1.51	-5.57	-5.73	-21.4	1.10	-13.1	1.66	-3.88
Financing	0	116	-0.55	7.60	-0.92	149	2.50	-1.37	-0.44	-6.87	-11.9	8.76	-8.67	13.0	-0.88	-8.07	-7.35	-7.86	-8.52	-7.38	-33.0	-1.86	-2.46	-1.66
Cash at period end	0	0.88	0.5	0.23	0.06	176	188	198	170	157	120	109	52.9	59.3	41.2	66.1	89.5	89.2	79.0	104	73.4	51.0	35.7	25.2

Profitability

Quarterly · %

Operating margin -24.4% Net margin -21.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	—	-0.2%	-0.8%	-0.4%	-0.4%	13.5%	8.6%	6.8%	4.0%	0.1%	-6.1%	1.3%	4.7%	5.9%	8.3%	6.2%	7.3%	-6.2%	-14.6%	-21.7%	-59.3%	-139.6%	-24.8%	-24.4%
Net margin	—	-0.2%	4.0%	-4.9%	0.6%	16.2%	8.0%	10.7%	2.4%	10.1%	-3.1%	1.1%	2.5%	2.4%	5.8%	4.0%	4.0%	-2.7%	-9.8%	-13.9%	-39.2%	-178.9%	-19.5%	-21.6%

Returns & leverage

Quarterly · %

ROE -92.4% ROA -64.7% Debt ratio 48.7%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	-24.0%	—	17.1%	22.4%	32.8%	34.4%	14.0%	8.5%	4.3%	4.9%	2.5%	7.5%	9.1%	9.2%	6.4%	-0.2%	-6.0%	-17.3%	-78.5%	-85.0%	-92.4%
ROA	—	—	—	-1.0%	-1.1%	9.0%	12.1%	18.5%	18.4%	9.8%	5.9%	3.1%	3.5%	1.6%	4.9%	6.2%	6.1%	4.2%	-0.1%	-4.1%	-12.2%	-54.2%	-58.7%	-64.7%
Debt ratio	—	3.6%	9.4%	11.8%	11.2%	26.7%	26.1%	23.3%	23.9%	29.1%	30.3%	27.3%	30.6%	37.8%	35.8%	34.9%	34.2%	30.8%	29.9%	29.5%	26.3%	42.0%	46.9%	48.7%

EPS

Quarterly · US$

EPS US$-0.16

Show table：EPS

Item	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	-0.25	-0.03	-18.19	0.04	0.25	0.09	0.11	0.03	0.10	-0.03	-0.02	0.05	0.07	0.10	0.06	0.05	-0.04	-0.09	-0.11	-0.28	-1.35	-0.15	-0.16

Revenue & profit

Year-to-date · In mn (USD)

Revenue 149 mn Net income -30.6 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 187 mn Total liabilities 91.0 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -13.9 mn Investing -2.22 mn Financing -4.13 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin -24.6% Net margin -20.5%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -92.4% ROA -64.7% Debt ratio 48.7%

EPS

Year-to-date · US$

EPS US$-0.31

Revenue & profit

Annual · In mn (USD)

Revenue 322 mn Net income -182 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2021	2022	2023	2024	2025
Revenue	319	441	624	617	322
Operating income	15.4	21.8	15.1	28.7	-178
Net income	19.2	34.6	7.31	20.0	-182

Balance sheet

Annual · In mn (USD)

Total assets 217 mn Total liabilities 91.2 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2021	2022	2023	2024	2025
Current assets	256	271	339	304	152
Total assets	310	393	490	456	217
Current liabilities	57.9	100	170	122	67.5
Total liabilities	82.5	114	185	140	91.2
Equity	220	273	301	321	144

Cash flow

Annual · In mn (USD)

Operating 34.5 mn Investing -39.1 mn Financing -50.8 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2021	2022	2023	2024	2025
Operating	-1.95	28.9	-64.2	70.3	34.5
Investing	-8.59	-38.5	-29.9	-10.9	-39.1
Financing	155	-6.18	1.12	-24.1	-50.8
Cash at period end	176	157	59.3	89.2	51.0

Profitability

Annual · %

Operating margin -55.3% Net margin -56.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2021	2022	2023	2024	2025
Operating margin	4.8%	5.0%	2.4%	4.7%	-55.3%
Net margin	6.0%	7.8%	1.2%	3.2%	-56.6%

Returns & leverage

Annual · %

ROE -78.5% ROA -54.2% Debt ratio 42.0%

Show table：Returns & leverage

Item	2021	2022	2023	2024	2025
ROE	8.7%	14.0%	2.5%	6.4%	-78.5%
ROA	6.2%	9.8%	1.6%	4.2%	-54.2%
Debt ratio	26.7%	29.1%	37.8%	30.8%	42.0%

EPS

Annual · US$

EPS US$-1.83

Show table：EPS

Item	2021	2022	2023	2024	2025
EPS（US$）	-17.93	0.33	0.07	0.17	-1.83

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read DocGo Inc. (DCGO) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.